PROJECT HELIX-HTT | Neuro-Oncology Vaccine Program
1. Purpose
The APC Cargo Atlas defines what antigen-presenting cells must carry, process, display, and signal in order to convert HELIX-VAX antigens into a durable anti-tumor immune response.
APC = Antigen-Presenting Cell, mainly:
APC Type | Primary Role |
Dendritic cells | Strongest T-cell priming |
Macrophages / microglia | CNS immune interpretation |
B cells | Secondary antigen presentation |
Monocytes | Inflammatory bridge APCs |
2. APC Cargo Categories
Cargo Class | Function | Vaccine Relevance |
Antigen cargo | Tumor peptides / neoantigens | Defines immune target |
HLA cargo | MHC-I / MHC-II complexes | Displays antigen |
Co-stimulatory cargo | CD80, CD86, CD40 | Activates T cells |
Cytokine cargo | IL-12, IFN-I, TNF-α | Shapes immune response |
Checkpoint cargo | PD-L1, CTLA4-related signals | May suppress response |
Metabolic cargo | redox / hypoxia state | Determines APC fitness |
Neuroimmune cargo | microglial activation signals | CNS safety control |
3. APC Cargo Atlas Table
Cargo ID | Cargo Type | Key Markers | Desired State | SCF Interpretation |
APC-C01 | Antigen peptide cargo | VAMI antigens | High fidelity | Correct tumor target loading |
APC-C02 | MHC-I cargo | HLA-A/B/C, B2M | High | CD8 T-cell activation |
APC-C03 | MHC-II cargo | HLA-DR/DQ/DP | Functional | CD4 helper support |
APC-C04 | Co-stimulation | CD80, CD86, CD40 | High | Immune activation enabled |
APC-C05 | Maturation cargo | CCR7, CD83 | High | Lymph node trafficking |
APC-C06 | Cytokine cargo | IL-12, IFN-α/β | Balanced-high | Durable anti-tumor priming |
APC-C07 | Suppression cargo | PD-L1, IL-10, IDO1 | Low | Avoid immune silencing |
APC-C08 | Redox cargo | GSH:GSSG, ROS load | Stable | APC metabolic competence |
APC-C09 | Hypoxia cargo | HIF-1α, CAIX | Low | Avoid hypoxia-impaired priming |
APC-C10 | Neuroimmune cargo | IBA1, TREM2, IL-1β | Balanced | CNS safety compatibility |
4. APC Cargo Flow
Tumor Antigen Uptake
↓
Antigen Processing
↓
MHC-I / MHC-II Loading
↓
Co-Stimulatory Signal Expression
↓
Cytokine Programming
↓
T-Cell Priming
↓
Memory Formation
↓
Tumor Killing5. SCF APC Cargo Quality Index
APC-CQI =
Antigen Loading Fidelity
+ MHC Presentation Strength
+ Co-Stimulation
+ Cytokine Support
+ Metabolic Fitness
+ Neuroimmune Compatibility
- Suppression Cargo
- Hypoxia BurdenScore | Interpretation |
≥85 | APC vaccine-ready |
70–84 | functional, optimize |
55–69 | weak priming risk |
<55 | not suitable |
6. HELIX-VAX APC Cargo Requirements
For HELIX-VAX-01, APCs must demonstrate:
Requirement | Minimum Standard |
Antigen uptake | detectable VAMI antigen processing |
MHC-I presentation | strong CD8-compatible display |
MHC-II presentation | helper T-cell support present |
CD80/CD86 | elevated after stimulation |
IL-12 / IFN-I | present but not excessive |
PD-L1 / IL-10 / IDO1 | controlled |
CNS safety | no excessive microglial inflammatory profile |
7. APC Cargo Failure Modes
Failure Mode | Meaning | Correction |
Poor antigen uptake | APC cannot internalize vaccine | optimize delivery platform |
Weak MHC-I loading | weak CD8 activation | adjust construct/linkers |
Low co-stimulation | T cells become anergic | improve adjuvant strategy |
Excess PD-L1 / IL-10 | immune suppression | add conditioning strategy |
High ROS / hypoxia burden | metabolically weak APCs | RHENOVA correction |
Hyperactive neuroimmune cargo | CNS inflammation risk | reduce adjuvant intensity |
8. Output Files
File | Description |
APC-01 | APC Cargo Marker Panel |
APC-02 | Antigen Loading Report |
APC-03 | MHC Presentation Report |
APC-04 | Co-Stimulation Report |
APC-05 | Suppression Cargo Report |
APC-06 | Neuroimmune Safety Cargo Report |
9. Status
APC Cargo Atlas: Complete
Next recommended deliverable: Dendritic Cell Activation Report (DV-04).